Grand Habtoor resort, Dubai and Online
Sylvie Meillerais started her career in research, in academia and industry, and moved to regulatory policy through positions in Brussels pharmaceutical trade associations, including EFPIA. She then joined MSD as Director Global Regulatory Policy in June 2015; in her current role, her expertise and knowledge of the European pharmaceutical environment serves to drive regulatory policy activities in the areas of CMC and Quality in the EU and globally. She is an active member of the EFPIA Manufacturing and Quality Experts Group and of the Middle East network, where she leads the Life Cycle Management efforts. She is further engaged in IFPMA CMC & Quality policy activities.
Sylvie is a French national and graduated from the University of Bordeaux II with a Maîtrise in Biochemistry and Microbiology in 1993, completed by a Diploma from the University of Kent at Canterbury in the UK (Erasmus programme).
Sylvie can be followed on linkedin.
Qutaiba Al Manaseer, is a Public affairs professional drawing on more than 15 years’ experience in the biopharmaceutical industry. He is the Government Affairs Director for the Middle East and Africa, and he is leading the COVID vaccine supply project in AstraZeneca in this region.
Qutaiba serves in the Emirates Health Economics Society board as the Media and Public Relations Chairman.
Qutaiba holds an MBA from the Swiss Business School, Switzerland and a bachelor’s degree in Pharmacy from the University of Jordan. He is completing a master’s in health economics from Barcelona School of Management.
Before joining AZ, Qutaiba was the strategic market access and pricing lead for GSK Gulf.
Qutaiba is a strong advocate for Diversity and Inclusion, and he was the Global Development Lead in the Executive committee of the Women Leadership Initiative in GSK.